Skip to Content

Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer

Download PQI pdf 0.23MB

Last Updated: July 13, 2025

By: Shelbie Gibbs, PharmD, BCOP

About this PQI

The purpose of this document is to discuss the clinical considerations and general management of patients treated with zanidatamab-hrii for unresectable or metastatic biliary tract cancer.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI